GSE185307
Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing
The Oxford Nanopore (ONT) platform provides portable and rapid genome sequencing, and its ability to natively profile DNA methylation without complex sample processing is attractive for clinical sequencing. We recently demonstrated ONT shallow whole-genome sequencing to detect copy number alterations (CNA) from the circulating tumor DNA (ctDNA) of cancer patients. Here, we show that cell-type and cancer-specific methylation changes can also be detected, as well as cancer-associated fragmentation signatures. This feasibility study suggests that ONT shallow WGS could be a powerful tool for liquid biopsy, especially real-time medical applications. Overall design: We reanalyzed 10 plasma cell-free DNA samples from an earlier published study (available at EGAD00001006888). Original data was raw Oxford Nanopore fast5s files, which we mapped and called 5mC levels.